The European Commission Health and Consumers Directorate-General (DG SANCO) published a staff working document (SWD) on the use of ‘–omics’ technologies in the development of personalised medicine on 31 October 2013.
The report focuses on
- the potential and issues with the use of –omics technologies in the research and development of personalised medicine and current EU research funding in the area;
- recent developments in EU legislation for placing medicinal products and medical devices on the market;
- factors affecting the uptake of personalised medicine in healthcare systems.
Officials have indicated that the report will not provide policy recommendations and that no legislative review is foreseen.